Solutions Ecosystems Reports Resources Data Pricing Login Book a demo
Power Law company profile

OpenEvidence

Health Tech & Medtech · Miami, United States · Founded 2022 Decacorn

AI-driven clinical decision support enhancing healthcare outcomes at the point of care

Valuation
$10–50B
Latest valuation · Jan/2026
Unlock exact value
Revenue
$100–500M
Latest reported FY
Unlock exact value
Headcount
100–500
Current team size
Unlock exact value

Investors

12 investors on OpenEvidence's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Ownership

Who owns OpenEvidence

Estimated cap table from Dealroom's shareholder data — share of equity by holder. Stakes as last recorded by Dealroom (Jan/2026). Percentages are indicative.

60% Founders

Some investors are hidden on this public profile. See the full cap table on Dealroom →

Global footprint

Where OpenEvidence has talent and traffic

Workforce by country
🇺🇸 United States · Miami HQ
Book a demo for the full country breakdown
Web traffic by country
11M monthly visits
across markets
🇺🇸 United States61.9%
🇨🇦 Canada5%
🇧🇷 Brazil3.7%
🇪🇸 Spain2.8%
🇩🇪 Germany2%
Top 5 markets shown

Talent graph

The shape of OpenEvidence's talent

Dealroom maps OpenEvidence's team person by person — pinpointing the standout operators and scoring them across the six dimensions investors underwrite. The counts and shape below are a public preview; the named individuals and exact scores live in the platform.

16 standout operatorsDealroom-flagged across the org
9 AI specialistsincl. 8 core researchers
112 employees mappedperson by person
DimensionScore
AI Talentlive Score hidden — book a demo
Engineering Score hidden — book a demo
Product Score hidden — book a demo
Go-to-market Score hidden — book a demo
Leadership Score hidden — book a demo
Research Score hidden — book a demo
Book a demo to unlock OpenEvidence's exact scores

Source: Dealroom Talent Intelligence. Public profiles show counts and the team's shape only — request a demo for the named individuals, per-person seniority and tenure, and team benchmarks vs peers.

Patent intelligence

$210k patent portfolio · 1 active families

Estimated portfolio value
$210k
<0.01% of valuation · 346.4× smaller than top peer Dental Monitoring ($73M)
1 active patent families
Where OpenEvidence innovates Computer programNeural network nnData scienceDocumentationQuestion answering

Where OpenEvidence concentrates vs peers

Each axis is a top-10 topic across OpenEvidence and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Capital deployed

OpenEvidence's 1 investments and acquisitions.

Every disclosed deal where OpenEvidence appeared as a backer or acquirer, 2025–2025. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.

Portfolio analysis

1 deals across OpenEvidence's capital deployment.

Where the deals concentrate by sector, stage, and decade.

By sectorCount
    By stageCount
      By periodCount

        02 · Portfolio market map

        OpenEvidence's portfolio, mapped.

        Each chip is one company. Pill colour shows round type — green for Seed, blue for Series A, purple for B/C+, pink for late-stage, amber for M&A. Bigger sectors keep their full list behind “+ N more”.

        Stage
        Period
        1 of 1 deals

        Market sentiment

        What the market is saying about OpenEvidence

        An AI-synthesized read of the highest-engagement posts about OpenEvidence on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

        Reading the room on X — pulling top posts and synthesizing themes…

        Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

        See OpenEvidence on the full Dealroom platform

        Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.